Organicell Working Capital

OCEL
 Stock
  

USD 0.041  0.0002  0.49%   

Organicell Regenerative Medicine fundamentals help investors to digest information that contributes to Organicell Regenerative's financial success or failures. It also enables traders to predict the movement of Organicell OTC Stock. The fundamental analysis module provides a way to measure Organicell Regenerative's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Organicell Regenerative otc stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Organicell Working Capital Analysis

Organicell Regenerative's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Working Capital 
 = 
Current Assets 
Current Liabilities 
More About Working Capital | All Equity Analysis

Current Organicell Regenerative Working Capital

    
  (520 K)  
Most of Organicell Regenerative's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organicell Regenerative Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Compare to competition

Based on the company's disclosures, Organicell Regenerative Medicine has a Working Capital of (520,000). This is 100.12% lower than that of the Healthcare sector and 100.1% lower than that of the Biotechnology industry. The working capital for all United States stocks is 100.04% higher than that of the company.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Organicell Fundamentals

About Organicell Regenerative Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Organicell Regenerative Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organicell Regenerative using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organicell Regenerative Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida. Organicell Regenerative operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Organicell Regenerative in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Organicell Regenerative's short interest history, or implied volatility extrapolated from Organicell Regenerative options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Organicell Regenerative using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check Organicell Regenerative Piotroski F Score and Organicell Regenerative Altman Z Score analysis. Note that the Organicell Regenerative information on this page should be used as a complementary analysis to other Organicell Regenerative's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Organicell OTC Stock analysis

When running Organicell Regenerative price analysis, check to measure Organicell Regenerative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organicell Regenerative is operating at the current time. Most of Organicell Regenerative's value examination focuses on studying past and present price action to predict the probability of Organicell Regenerative's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Organicell Regenerative's price. Additionally, you may evaluate how the addition of Organicell Regenerative to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Organicell Regenerative's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organicell Regenerative. If investors know Organicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organicell Regenerative listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Organicell Regenerative is measured differently than its book value, which is the value of Organicell that is recorded on the company's balance sheet. Investors also form their own opinion of Organicell Regenerative's value that differs from its market value or its book value, called intrinsic value, which is Organicell Regenerative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organicell Regenerative's market value can be influenced by many factors that don't directly affect Organicell Regenerative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organicell Regenerative's value and its price as these two are different measures arrived at by different means. Investors typically determine Organicell Regenerative value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organicell Regenerative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.